• SIGN IN
  • GET HELP
  •  

    Home Study Details


    Program Type

    Home Study Webcast

    Credits

    1 Contact Hour(s)

    Release Date

    Thursday, October 24, 2019

    Offline Date

    Sunday, October 24, 2021

    ACPE Expiration Date

    Sunday, April 24, 2022

    Target Audience

    Pharmacist, Pharmacy Technician, Nurse

    Cost

    $4.00

    • Overview

      In November of 2017 HEPLISAV-B was approved for the prevention of hepatitis B. HePLISAV-B is a two-dose vaccine administered 4 weeks apart. It will be important for health care providers to be aware of these new options. Health care providers will need to understand how HEPLISAV-B compares to other commercially available hepatitis B vaccines. In addition, numerous limitations exist with the oral antiviral medications currently used to treat patients chronically infected with hepatitis B. New research is promising that we will have new oral antiviral therapies in the next 5 years. We will review the limitations with the current treatments and discuss agents that are currently in the pipeline.

      Handouts

      • Slide Document :   19077H06_2pp.pdf
      • Slide Document :   19077H06_6pp.pdf

      Financial Support By

      PharmCon
    • Pharmacist

      Identify limitations with current oral antiviral medications to treat hepatitis B
      Recognize the epidemiology of hepatitis B
      Compare and contrast commercially available hepatitis B vaccines

      Pharmacy Technician

      Compare and contrast commercially available hepatitis B vaccines
      Recognize the epidemiology of hepatitis B
      Identify limitations with current oral antiviral medications to treat hepatitis B

      Nurse

      Identify limitations with current oral antiviral medications to treat hepatitis B
      Recognize the epidemiology of hepatitis B
      Compare and contrast commercially available hepatitis B vaccines
    • Activity Type

      Knowledge

      CE Broker

      20-663217

      Universal Activity Number

      Pharmacist 0798-0000-19-077-H06-P
      Pharmacy Technician 0798-0000-19-077-H06-T
      Nurse 0798-0000-19-077-H06-N

      ACPE PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

      PharmCon is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

      In order to obtain a Statement of Credit, participants must score no less than a 70% on the activity's test and complete a program evaluation.


    HARDWARE REQUIREMENTS
    Standard Windows/Mac System
    iPad or iPhone
    Minimum screen resolution: 1024x768
    Speakers or headphones
     


    SOFTWARE REQUIREMENTS
    Microsoft Edge
    Internet Explorer 8.0 or higher
    Google Chrome
    Safari
    Firefox 3.0.3 or higher


    NETWORK REQUIREMENTS
    Broadband Internet Connection:
    T1, Hi-speed DSL or Cable
    4G cellular connection
     
     

    This continuing education activity is held as copyright by PharmCon, Inc. Through this notice, PharmCon, Inc. grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).